, Tracking Stock Market Picks
Enter Symbol:
Boston Scientific Corporation (BSX) [hlAlert]

Neutral BSX
down 3.65 %

Boston Scientific Corporation (BSX) downgraded to Neutral with price target $7.65 by UBS

Posted on: Friday,  Jun 24, 2011  10:25 AM ET by UBS

UBS rated Neutral Boston Scientific Corporation (NYSE: BSX) on 06/24/2011. Previously UBS rated Buy Boston Scientific Corporation (NYSE: BSX) on 03/16/2010.,
when the stock price was $7.12. Since then, Boston Scientific Corporation has lost 3.65% as of 06/24/2011's recent price of $6.86.
If you would have followed the previous UBS's recommendation on BSX, you would have lost 3.65% of your investment in 465 days.

Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary medicine, radiology, urology and vascular surgery.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/24/2011 10:25 AM Hold
6.86 7.65
as of 12/30/2011
1 Week   
1 Month   
3 Months   
1 YTD down  -9.37 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/16/2010 11:25 AM Buy
7.12 8.00
9/14/2009 11:25 AM Hold
11.19 12.00
11/20/2008 8:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy